Cleeland, C. S., Zhao, F., Chang, V. T., et al. (2013). The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer, 119(24), 4333–4340.
Reilly, C. M., Bruner, D. W., Mitchell, S. A., et al. (2013). A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Supportive Care in Cancer, 21(6), 1525–1550.
Article PubMed PubMed Central Google Scholar
Panattoni, L., Fedorenko, C., Greenwood-Hickman, M. A., et al. (2018). Characterizing potentially preventable cancer- and chronic disease-related emergency department use in the year after treatment initiation: A regional study. Journal of Oncology Practice/American Society of Clinical Oncology, 14(3), e176–e185.
Henry, D. H., Viswanathan, H. N., Elkin, E. P., et al. (2008). Symptoms and treatment burden associated with cancer treatment: Results from a cross-sectional national survey in the US. Supportive Care in Cancer, 16(7), 791–801.
Schmidt, T., Valuck, T., Perkins, B., et al. (2021). Improving patient-reported measures in oncology: A payer call to action. Journal of Managed Care and Specialty Pharmacy, 27(1), 118–126.
Centers for Medicare & Medicaid Services (CMS). Enhancing oncology model. https://innovation.cms.gov/innovation-models/enhancing-oncology-model.
Basch, E., Schrag, D., Henson, S., et al. (2022). Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: A randomized clinical trial. JAMA, 327(24), 2413–2422.
Article PubMed PubMed Central Google Scholar
National Cancer Institute. Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events. https://healthcaredelivery.cancer.gov/pro-ctcae/.
Dueck, A. C., Mendoza, T. R., Mitchell, S. A., et al. (2015). Validity and reliability of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncology, 1(8), 1051–1059.
Article PubMed PubMed Central Google Scholar
Al-Rashdan, A., Sutradhar, R., Nazeri-Rad, N., et al. (2021). Comparing the ability of physician-reported versus patient-reported performance status to predict survival in a population-based cohort of newly diagnosed cancer patients. Clinical Oncology (Royal College of Radiologists), 33(7), 476–482.
Stover, A. M., Tompkins Stricker, C., Hammelef, K., et al. (2019). Using stakeholder engagement to overcome barriers to implementing patient-reported outcomes (PROs) in cancer care delivery: Approaches from 3 prospective studies. Medical Care, 57(5), S92–S99.
Kiernan, K. (2018). Insights into using the GLIMMIX procedure to model categorical outcomes with random effects. SAS Technical Papers, 2018, 1–23.
Basch, E., Stover, A. M., Schrag, D., et al. (2020). Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: Findings from the PRO-TECT trial. JCO Clinical Cancer Informatics, 4, 947–957.
Mandrekar, J. N. (2010). Receiver operating characteristic curve in diagnostic test assessment. Journal of Thoracic Oncology, 5(9), 1315–1316.
留言 (0)